Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 214

1.

The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines.

Deer TR, Pope JE, Hayek S, Bux A, Buchser E, Eldabe S, De Andrés JA, Erdek M, Patin D, Grider JS, Doleys DM, Jacobs MS, Yaksh TL, Poree L, Wallace MS, Prager J, Rauck R, DeLeon O, Diwan S, Falowski SM, Gazelka HM, Kim P, Leong M, Levy RM, McDowell Ii G, McRoberts P, Naidu R, Narouze S, Perruchoud C, Rosen SM, Rosenberg WS, Saulino M, Staats P, Stearns LJ, Willis D, Krames E, Huntoon M, Mekhail N.

Neuromodulation. 2017 Jan 2. doi: 10.1111/ner.12538. [Epub ahead of print] Review.

PMID:
28042904
2.

T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance System.

Huang WC, Easom NJ, Tang XZ, Gill US, Singh H, Robertson F, Chang C, Trowsdale J, Davidson BR, Rosenberg WM, Fusai G, Toubert A, Kennedy PT, Peppa D, Maini MK.

J Immunol. 2016 Dec 28. pii: 1601313. doi: 10.4049/jimmunol.1601313. [Epub ahead of print]

PMID:
28031333
3.

Comparison of the low contrast detectability of two ultrasound systems using a greyscale phantom.

Lorentsson R, Hosseini N, Johansson JO, Rosenberg W, Stenborg B, Månsson LG, Båth M.

J Appl Clin Med Phys. 2016 Nov 8;17(6):6246.

PMID:
27929509
4.

Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy.

Tanwar S, Trembling PM, Hogan BJ, Srivastava A, Parkes J, Harris S, Grant P, Nastouli E, Ocker M, Wehr K, Herold C, Neureiter D, Schuppan D, Rosenberg WM.

Eur J Gastroenterol Hepatol. 2016 Nov 30. [Epub ahead of print]

PMID:
27906753
5.
6.

Clinical outcomes of pancreaticoduodenectomy in octogenarians: a surgeon's experience from 2007 to 2015.

Liang DH, Shirkey BA, Rosenberg WR, Martinez S.

J Gastrointest Oncol. 2016 Aug;7(4):540-6. doi: 10.21037/jgo.2016.03.04.

7.

MASTERS-D Study: A Prospective, Multicenter, Pragmatic, Observational, Data-Monitored Trial of Minimally Invasive Fusion to Treat Degenerative Lumbar Disorders, One-Year Follow-Up.

Franke J, Manson N, Buzek D, Kosmala A, Hubbe U, Rosenberg W, Pereira P, Assietti R, Martens F, Lam K, Barbanti Brodano G, Durny P, Lidar Z, Scheufler K, Senker W.

Cureus. 2016 Jun 13;8(6):e640. doi: 10.7759/cureus.640.

8.

Biomarkers of Hepatic Fibrosis in Chronic Hepatitis C: A Comparison of 10 Biomarkers Using 2 Different Assays for Hyaluronic Acid.

Tanwar S, Trembling PM, Hogan BJ, Parkes J, Harris S, Grant P, Nastouli E, Ocker M, Wehr K, Herold C, Neureiter D, Schuppan D, Rosenberg WM.

J Clin Gastroenterol. 2016 Jul 1. [Epub ahead of print]

PMID:
27380461
9.

Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon.

D'Ambrosio R, Degasperi E, Aghemo A, Fraquelli M, Lampertico P, Rumi MG, Facchetti F, Grassi E, Casazza G, Rosenberg W, Bedossa P, Colombo M.

PLoS One. 2016 Jun 15;11(6):e0155967. doi: 10.1371/journal.pone.0155967.

10.

The Social Work Role in Reducing 30-Day Readmissions: The Effectiveness of the Bridge Model of Transitional Care.

Alvarez R, Ginsburg J, Grabowski J, Post S, Rosenberg W.

J Gerontol Soc Work. 2016 Apr;59(3):222-7. doi: 10.1080/01634372.2016.1195781.

PMID:
27276523
11.

Isolated Hepatitis B Core Antibody Status Is Not Associated With Accelerated Liver Disease Progression in HIV/Hepatitis C Coinfection.

French AL, Hotton A, Young M, Nowicki M, Augenbraun M, Anastos K, Seaberg E, Rosenberg W, Peters MG.

J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):274-80. doi: 10.1097/QAI.0000000000000969.

PMID:
26918547
12.

Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.

Swanson S, Ma Y, Scherzer R, Huhn G, French AL, Plankey MW, Grunfeld C, Rosenberg WM, Peters MG, Tien PC.

J Infect Dis. 2016 Apr 1;213(7):1079-86. doi: 10.1093/infdis/jiv567.

PMID:
26621911
13.

Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV.

Peters MG, Bacchetti P, Boylan R, French AL, Tien PC, Plankey MW, Glesby MJ, Augenbraun M, Golub ET, Karim R, Parkes J, Rosenberg W.

AIDS. 2016 Mar 13;30(5):723-9. doi: 10.1097/QAD.0000000000000975.

PMID:
26595542
14.

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.

Foster GR, Afdhal N, Roberts SK, Bräu N, Gane EJ, Pianko S, Lawitz E, Thompson A, Shiffman ML, Cooper C, Towner WJ, Conway B, Ruane P, Bourlière M, Asselah T, Berg T, Zeuzem S, Rosenberg W, Agarwal K, Stedman CA, Mo H, Dvory-Sobol H, Han L, Wang J, McNally J, Osinusi A, Brainard DM, McHutchison JG, Mazzotta F, Tran TT, Gordon SC, Patel K, Reau N, Mangia A, Sulkowski M; ASTRAL-2 Investigators.; ASTRAL-3 Investigators..

N Engl J Med. 2015 Dec 31;373(27):2608-17. doi: 10.1056/NEJMoa1512612.

15.

Broad Access to Treatment is Cost-Effective for Patients with Chronic Hepatitis C in England.

Treharne C, Howells R, Rosenberg W.

Value Health. 2015 Nov;18(7):A588. doi: 10.1016/j.jval.2015.09.1506. No abstract available.

16.

Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries.

Younossi Z, Brown A, Buti M, Fagiuoli S, Mauss S, Rosenberg W, Serfaty L, Srivastava A, Smith N, Stepanova M, Beckerman R.

J Viral Hepat. 2016 Mar;23(3):217-26. doi: 10.1111/jvh.12483.

PMID:
26482680
17.

Letter: A Survey of Chronic Pain Due to Spinal Dural Arteriovenous Fistulae.

Rosenberg WS.

Neurosurgery. 2016 Jan;78(1):E161-2. doi: 10.1227/NEU.0000000000001031. No abstract available.

PMID:
26407131
18.

Peripheral Nerve Stimulation for Pain in Extremities: An Update.

Pope JE, Carlson JD, Rosenberg WS, Slavin KV, Deer TR.

Prog Neurol Surg. 2015;29:139-57. doi: 10.1159/000434667. Review.

PMID:
26393784
19.

Bypass grafting between the supraceliac aorta and the common hepatic artery during pancreaticoduodenectomy.

Liang DH, Rosenberg WR, Martinez S.

J Surg Case Rep. 2015 Sep 1;2015(9). pii: rjv107. doi: 10.1093/jscr/rjv107.

20.

IL28B genotype predicts response to chronic hepatitis C triple therapy with telaprevir or boceprevir in treatment naïve and treatment-experienced patients other than prior partial- and null-responders.

Calisti G, Tavares A, Macartney MJ, McCormick A, Labbett W, Jacobs M, Dusheiko G, Rosenberg WM, Haque T.

Springerplus. 2015 Jul 16;4:357. doi: 10.1186/s40064-015-1137-x.

Items per page

Supplemental Content

Loading ...
Support Center